Publications

5808 Results

Accurate classification of diffuse large cell lymphoma into germinal center and activated B cell subtypes using a nuclease protection assay on formalin fixed paraffin embedded: a study from the Lymphoma and Leukemia Molecular Profiling Project

Authors
LM Rimsza;GL Wright;M Schwartz;J Chan;E Jaffe;R Gascoyne;E Campo;A Rosenwald;G Ott;J Cook;RR Tubbs;R Braziel;J Delabie;T Miller;RI Fisher;L Staudt
Journal / Conference
Blood 114:abst. #620, 2009 (ASH Annual Meeting, oral presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

High microvascular density correlates independently with poor outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab plus chemotherapy (R-CT)

Authors
T Cardesa;L Colomo;F Climent;E Gonzalez-Barca;G Gutierrez;M Mercadal;R Gascoyne;JM Connors;LM Rimsza;RM Braziel;J Cook;R Tubbs;A Rosenwald;G Ott;J Mate;J Ribera;L Arenillas;S Serrano;N Combalia;J Delabie;G Lenz;G Wright;E Jaffe;L Staudt;W Chan;D Weissenburger;A Lopez-Guillermo;E Campo
Journal / Conference
Blood 114:abst. #1948 (ASH Annual Meeting, poster presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Chromosomal alterations in gene expression-defined pediatric aggressive B-cell non-hodgkin lymphomas (B-NHL)

Authors
K Deffenbacher;J Iqbal;Z Liu;S Perkins;M Lim;K Fu;J Shen;L Staudt;L Rimsza;E Jaffe;A Rosenwald;J Delabie;J Campo;R Gascoyne;D Weisenberger;T Greiner;TG Gross;W Chan
Journal / Conference
Blood 114 abst. #2922 (ASH Annual Meeting, poster presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

MYC translocations and expression are clinically important in R-CHOP treated patients with de novo DLBCL

Authors
NA Johnson;S Ben-Neriah;KJ Savage;T Lee;DE Horsman;JM Connors;WC Chan;G Lenz;G Wright;L Rimsza;RM Braziel;J Cook;R Tubbs;D Weisenburger;E Campo;A Rosenwald;G Ott;J Delabie;E Jaffe;LM Staudt;RD Gascoyne
Journal / Conference
Blood 114:abst. 1100 (ASH Annual Meeting, poster presentation)
Year
2009
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Preliminary results of Southwest Oncology Group study S0106: an international intergroup phase 3 randomized trial comparing the addition of gemtuzumab ozogamicin to standard induction therapy versus standard induction therapy followed by a second randomization to no additional therapy versus post-consolidation gemtuzumab ozogamicin for previously untreated acute myeloid leukemia

Authors
SH Petersdorf;KJ Kopecky;RK Stuart;TJ Nevill;R Larson;L Stenke;M Tallman;M Slovak;C Willman;H Erba;F Appelbaum
Journal / Conference
Blood 114:abst. #790
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
S0106

Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status [PMC2734394; PMID19620488]

Authors
RR Tubbs;W Barlow;GT Budd;E Swain;P Porter;AM Gown;IT Yeh;G Sledge;S Shapiro;J Ingle;C Haskell;KS Albain;RB Livingston;DF Hayes
Journal / Conference
Journal of Clinical Oncology, 27(24):3881-3886
Year
2009
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. PMC2682694;PMID: 19117055.

Authors
S Sutcliffe;JF Alderete;C Till;P Goodman;A Hsing;JL Zenilman;AM Demarzo;EA Platz
Journal / Conference
International Journal of Cancer 124(9)2082-2087
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Serum adiponectin, c-peptide and leptin and risk of symptomatic beign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial

Authors
JM Shenk;AR Kristal;ML Neuhouser;CM Tangen;E White;DW Lin
Journal / Conference
Prostate 69(12):1303-1311
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial

Authors
Z Gong;AR Kristal;JM Schenk;CM Tangen;P Goodman;IM Thompson
Journal / Conference
Cancer 1154(16):3661-3669
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

The performance of PSA for predicting prostate cancer after a prior negative prostate biopsy

Authors
CM Tangen
Journal / Conference
Prostate Cancer Screening, 2nd edition, D Ankerst, IM Thompson, C Tangen, eds., Human Press, New York, NY, ch 7, pp 71-78
Year
2009
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217